Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125408291 | 12540829 | 1 | I | 2006 | 20160630 | 20160708 | 20160708 | EXP | CA-AMGEN-CANSP2016087584 | AMGEN | 87.00 | YR | E | F | Y | 0.00000 | 20160708 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125408291 | 12540829 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | UNK | U | 103795 | UNKNOWN FORMULATION | ||||||||
| 125408291 | 12540829 | 2 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Oral | 200 MG, BID | 0 | 200 | MG | BID | |||||||
| 125408291 | 12540829 | 3 | SS | ARTHROTEC | DICLOFENAC SODIUMMISOPROSTOL | 1 | Unknown | UNK | 0 | ||||||||||
| 125408291 | 12540829 | 4 | SS | ORENCIA | ABATACEPT | 1 | Unknown | UNK | 0 | ||||||||||
| 125408291 | 12540829 | 5 | C | ASPIRIN. | ASPIRIN | 1 | Unknown | 81 MG, QD (6 TABLETS DAILY) | 0 | 81 | MG | QD | |||||||
| 125408291 | 12540829 | 6 | C | METHOTREXATE. | METHOTREXATE | 1 | Oral | 2.5 MG, QWK (4 TABLETS) | 0 | 2.5 | MG | /wk | |||||||
| 125408291 | 12540829 | 7 | C | TYLENOL | ACETAMINOPHEN | 1 | Oral | UNK UNK, QD (3 TABLETS) | 0 | QD | |||||||||
| 125408291 | 12540829 | 8 | C | ARAVA | LEFLUNOMIDE | 1 | 10 MG, BID | 0 | 10 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125408291 | 12540829 | 1 | Product used for unknown indication |
| 125408291 | 12540829 | 2 | Product used for unknown indication |
| 125408291 | 12540829 | 3 | Product used for unknown indication |
| 125408291 | 12540829 | 4 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125408291 | 12540829 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125408291 | 12540829 | Blood test abnormal | |
| 125408291 | 12540829 | Drug ineffective | |
| 125408291 | 12540829 | Joint arthroplasty | |
| 125408291 | 12540829 | Macular degeneration | |
| 125408291 | 12540829 | Rheumatoid arthritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125408291 | 12540829 | 4 | 2013 | 2015 | 0 | |
| 125408291 | 12540829 | 6 | 1968 | 0 | ||
| 125408291 | 12540829 | 8 | 201104 | 201105 | 0 |